DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Aedifica NV/SA

ENXTBR:AED Stock Report

Market Cap: €5.5b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Aedifica/SA Past Earnings Performance

Past criteria checks 4/6

Aedifica/SA has been growing earnings at an average annual rate of 6.2%, while the Health Care REITs industry saw earnings growing at 10.4% annually. Revenues have been growing at an average rate of 12.7% per year. Aedifica/SA's return on equity is 9.1%, and it has net margins of 132%.

Key information

6.22%

Earnings growth rate

-7.32%

EPS growth rate

Health Care REITs Industry Growth0.61%
Revenue growth rate12.74%
Return on equity9.07%
Net Margin132.03%
Next Earnings Update18 Nov 2026

Recent past performance updates

Recent updates

User avatar
Narrative Update • Jun 26

AED: Special Meetings Will Refocus Market Attention On Upgraded Earnings Outlook

Analysts have adjusted their view on Aedifica SA, lifting the indicative fair value from about €74.06 to €83.00 as they update assumptions on the discount rate, revenue growth, profit margin and future P/E levels. What's in the News Aedifica/SA has scheduled a Special/Extraordinary Shareholders Meeting on 12 May 2026 at 14:45 Romance Standard Time, according to company event notices.

Revenue & Expenses Breakdown

How Aedifica/SA makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTBR:AED Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 26485641350
31 Mar 26391614330
31 Dec 25369244320
30 Sep 25367228340
30 Jun 25361176350
31 Mar 25358192340
31 Dec 24347205330
30 Sep 24341106340
30 Jun 24334110340
31 Mar 2432784350
31 Dec 2332125340
30 Sep 2331243320
30 Jun 23301150310
31 Mar 23290231310
31 Dec 22279332320
30 Sep 22273489320
30 Jun 22265408310
31 Mar 22254354320
31 Dec 21243282280
30 Sep 21216221270
30 Jun 21198193250
31 Mar 21188150250
31 Dec 20179115240
30 Jun 20169105230
31 Mar 20157129200
31 Dec 19146154170
30 Sep 19134139150
30 Jun 19122123150
31 Mar 1911199130
31 Dec 1810074110
30 Sep 189773110
30 Jun 189472100
31 Mar 189272100
31 Dec 17897390
30 Sep 17856890
30 Jun 17826380
31 Mar 17765480
31 Dec 16714470
30 Sep 16664270
30 Jun 16624060
31 Mar 16604460
31 Dec 15584760
30 Sep 15554650

Quality Earnings: AED has a large one-off gain of €359.7M impacting its last 12 months of financial results to 30th June, 2026.

Growing Profit Margin: AED's current net profit margins are higher than last year (48.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AED's earnings have grown by 6.2% per year over the past 5 years.

Accelerating Growth: AED's earnings growth over the past year (264.5%) exceeds its 5-year average (6.2% per year).

Earnings vs Industry: AED earnings growth over the past year (264.5%) exceeded the Health Care REITs industry 72.4%.


Return on Equity

High ROE: AED's Return on Equity (9.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/13 17:05
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aedifica NV/SA is covered by 21 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kanad MitraBarclays
Celine HuynhBarclays
Kai KloseBerenberg

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide